tiprankstipranks
Trending News
More News >
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market

4D Molecular Therapeutics (FDMT) Ratios

Compare
515 Followers

4D Molecular Therapeutics Ratios

FDMT's free cash flow for Q3 2025 was $-523.87. For the 2025 fiscal year, FDMT's free cash flow was decreased by $ and operating cash flow was $-631.96. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
8.42 14.92 15.65 14.02 15.69
Quick Ratio
8.42 14.92 15.65 14.02 15.69
Cash Ratio
1.31 5.12 13.14 3.33 9.36
Solvency Ratio
-3.82 -3.10 -3.01 -3.44 -2.03
Operating Cash Flow Ratio
-4.95 -4.62 -4.00 -5.51 -4.23
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 -32.65 0.00
Net Current Asset Value
$ 257.38M$ 385.15M$ 264.53M$ 190.00M$ 221.90M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.04 0.04 0.06 0.05
Debt-to-Equity Ratio
0.06 0.05 0.05 0.07 0.05
Debt-to-Capital Ratio
0.06 0.05 0.05 0.07 0.05
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.15 1.10 1.10 1.13 1.11
Debt Service Coverage Ratio
0.00 0.00 0.00 -40.54 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 <0.01 0.00
Interest Debt Per Share
0.40 0.46 0.37 0.50 0.59
Net Debt to EBITDA
0.12 0.69 2.16 0.34 1.96
Profitability Margins
Gross Profit Margin
-80710.83%100.00%-368.54%-2464.81%-240.17%
EBIT Margin
-188391.67%-507678.38%-544.65%-3516.52%-395.46%
EBITDA Margin
-189008.33%-489556.76%-524.36%-3439.73%-387.02%
Operating Profit Margin
-191982.50%-507678.38%-544.65%-3516.52%-395.46%
Pretax Profit Margin
-174314.17%-434778.38%-486.59%-3435.41%-395.37%
Net Profit Margin
-174314.17%-434778.38%-486.59%-3435.41%-395.37%
Continuous Operations Profit Margin
-174314.17%-434778.38%-486.59%-3435.41%-395.37%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
90.80%85.64%89.34%97.69%99.98%
Return on Assets (ROA)
-49.34%-28.71%-29.67%-41.05%-20.18%
Return on Equity (ROE)
-47.27%-31.51%-32.76%-46.47%-22.35%
Return on Capital Employed (ROCE)
-59.55%-35.36%-35.17%-44.71%-21.16%
Return on Invested Capital (ROIC)
-58.68%-34.99%-34.83%-44.23%-21.08%
Return on Tangible Assets
-49.34%-28.71%-29.67%-41.05%-20.18%
Earnings Yield
-41.73%-53.54%-12.72%-14.96%-11.72%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 4.47 383.79
Payables Turnover
14.13 0.00 27.62 24.16 12.88
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
<0.01 <0.01 0.65 0.09 0.62
Asset Turnover
<0.01 <0.01 0.06 0.01 0.05
Working Capital Turnover Ratio
<0.01 <0.01 0.09 0.01 0.07
Cash Conversion Cycle
-25.83 0.00 -13.21 66.55 -27.39
Days of Sales Outstanding
0.00 0.00 0.00 81.66 0.95
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
25.83 0.00 13.21 15.11 28.34
Operating Cycle
0.00 0.00 0.00 81.66 0.95
Cash Flow Ratios
Operating Cash Flow Per Share
-3.27 -2.49 -1.94 -2.68 -2.49
Free Cash Flow Per Share
-3.30 -2.57 -2.01 -3.04 -2.82
CapEx Per Share
0.03 0.07 0.07 0.36 0.33
Free Cash Flow to Operating Cash Flow
1.01 1.03 1.04 1.13 1.13
Dividend Paid and CapEx Coverage Ratio
-118.00 -35.55 -27.35 -7.51 -7.59
Capital Expenditure Coverage Ratio
-118.00 -35.55 -27.35 -7.51 -7.59
Operating Cash Flow Coverage Ratio
-8.24 -5.47 -5.17 -5.38 -4.20
Operating Cash Flow to Sales Ratio
-1.53K -3.64K -3.66 -27.70 -3.83
Free Cash Flow Yield
-40.63%-46.05%-9.91%-13.67%-12.86%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.40 -1.87 -7.86 -6.68 -8.53
Price-to-Sales (P/S) Ratio
3.80K 8.12K 38.26 229.63 33.73
Price-to-Book (P/B) Ratio
1.36 0.59 2.58 3.11 1.91
Price-to-Free Cash Flow (P/FCF) Ratio
-2.46 -2.17 -10.09 -7.32 -7.78
Price-to-Operating Cash Flow Ratio
-2.73 -2.23 -10.46 -8.29 -8.80
Price-to-Earnings Growth (PEG) Ratio
0.38 -0.12 0.45 -0.25 -0.53
Price-to-Fair Value
1.36 0.59 2.58 3.11 1.91
Enterprise Value Multiple
-1.89 -0.97 -5.14 -6.34 -6.76
Enterprise Value
429.21M 175.74M 558.34M 682.29M 471.85M
EV to EBITDA
-1.89 -0.97 -5.14 -6.34 -6.76
EV to Sales
3.58K 4.75K 26.94 218.05 26.16
EV to Free Cash Flow
-2.32 -1.27 -7.11 -6.95 -6.03
EV to Operating Cash Flow
-2.34 -1.31 -7.37 -7.87 -6.83
Tangible Book Value Per Share
6.57 9.47 7.87 7.15 11.51
Shareholders’ Equity Per Share
6.57 9.47 7.87 7.15 11.51
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 <0.01 0.53 0.10 0.65
Net Income Per Share
-3.73 -2.98 -2.58 -3.32 -2.57
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
0.93 0.86 0.89 0.98 1.00
Research & Development to Revenue
1.51K 3.82K 4.69 25.65 3.40
SG&A to Revenue
411.05 1.26K 1.76 10.52 1.55
Stock-Based Compensation to Revenue
200.34 705.84 0.95 5.47 0.76
Income Quality
0.88 0.84 0.75 0.81 0.97
Currency in USD